Nid yw'r tudalen hwn ar gael yn Gymraeg ar hyn o bryd. Dyma'r fersiwn Saesneg.

Mesurau Gwella

Transformational Step: 2

Agree across the health community what data/information is required to measure the success of local and national clinical outcomes.

Intended Outcome

Improved quality of USC Services as evidenced by whole system USC clinical outcome measures.

Using clinical outcomes can help measure the success of the whole USC system from chronic disease management, through intermediate care to acute hospital services.

High level outcome measures indicated nationally include;
  • Access time sensitive conditions- myocardial infarction (MI), stroke, sepsis, major trauma and fractured neck of femur.
  • Ambulatory care sensitive conditions-chronic disease exacerbations

The Annual Quality Framework 2011/12 (AQF) pays particular attention to:

  • Patient experience
  • Access time critical conditions such as MI, stroke, fractured neck of femur, major trauma and sepsis
  • Ambulatory care conditions i.e. individual conditions or patients that would be more appropriately treated in a non-hospital setting, e.g. chronic disease type exacerbations such as asthma, heart failure, diabetes, COPD, epilepsy, some falls, frail elderly and end of life care; acute social care and acute medical conditions e.g. deep vein thrombosis (DVT), thrombosis, cellulitis and chest infections.

A challenge for LHBs is to develop reliable, contemporaneous local processes and outcome data that can be scrutinised by clinical teams to stimulate and maintain continual improvement of high quality services.

The 1000 Lives Plus programme and intelligent target approach to acute stroke care can provide significant learning on the use of a care bundle approach to achieve outcomes.